Cargando…
Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
Symptomatic ulcerative colitis (UC) can be a chronic, disabling condition. Flares in disease activity are associated with many of the negative impacts of mild-to-moderate UC. Rapid resolution of flares can provide benefits to patients and healthcare systems. i Support Therapy–Access to Rapid Treatme...
Autores principales: | Danese, Silvio, Banerjee, Rupa, Cummings, JR Fraser, Dotan, Iris, Kotze, Paulo G, Leong, Rupert Wing Loong, Paridaens, Kristine, Peyrin-Biroulet, Laurent, Scott, Glyn, Assche, Gert Van, Wehkamp, Jan, Yamamoto-Furusho, Jesús K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223445/ https://www.ncbi.nlm.nih.gov/pubmed/30321913 http://dx.doi.org/10.5217/ir.2018.00073 |
Ejemplares similares
-
iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis
por: D’Amico, Ferdinando, et al.
Publicado: (2023) -
Implementation of a Smartphone application in medical education: a randomised trial (iSTART)
por: Martínez, Felipe, et al.
Publicado: (2017) -
Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
por: Solitano, Virginia, et al.
Publicado: (2020) -
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2023) -
Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic
por: Kotze, Paulo Gustavo, et al.
Publicado: (2021)